Diabetes

**Kallistatin Breakthrough: Weight Loss Boosts Metabolism to Combat Obesity and Type 2 Diabetes**

by

A recent study conducted in Tübingen, Germany, has unveiled a fascinating discovery regarding weight loss and its impact on individuals with obesity and type 2 diabetes. The research reveals that shedding excess pounds triggers an increase in the levels of a protein called Kallistatin in the subcutaneous white adipose tissue of individuals with overweight or obesity. This finding suggests a potential avenue for innovative treatments aimed at addressing the intricate challenges posed by obesity and …

Read more

**Diabetes Lawsuit Sparks Scandal: ADA’s Betrayal Revealed**

by

New York, NY – A recent whistleblower lawsuit has shed light on a controversial case involving the American Diabetes Association (ADA) and its alleged acceptance of corporate funds in exchange for promoting recipes that could jeopardize the health of individuals with diabetes. The lawsuit, brought forward by former ADA chief nutritionist Elizabeth Hanna, accused the organization of pressuring her to endorse recipes containing artificial sweeteners, such as Splenda, despite potential risks to diabetes patients. Hanna …

Read more

Investigation Launched into Novo Nordisk’s High Cost of Diabetes Treatments by Sen. Bernie Sanders

by

Washington, D.C. – Senator Bernie Sanders, known for his advocacy on healthcare issues, has set his sights on scrutinizing the prices of two popular drugs, Ozempic and Wegovy. The independent senator from Vermont is concerned about the exorbitant prices set by Novo Nordisk for these medications, which are used to treat type 2 diabetes and aid in weight loss. In a letter to Novo Nordisk’s CEO, Sanders highlighted the importance of these drugs for millions …

Read more

**Sleep** Less Than 6 Hours Increases Risk of Type 2 Diabetes – What You Need to Know!

by

Sydney, Australia – Not getting enough sleep is a widespread issue in today’s fast-paced society. A recent study has revealed a concerning link between insufficient sleep and an increased risk of developing type 2 diabetes. The study, conducted using data from the UK Biobank, followed over 200,000 adults for more than a decade to analyze the relationship between sleep duration, diet, and diabetes risk. Participants in the study were asked about their daily sleep habits, …

Read more

**Diabetes Epidemic Exposed: ADA Funded by Big Pharma**

by

Miami, Florida – The influence of big business on the American healthcare system can be seen through the American Diabetes Association (ADA), the leading diabetes advocacy and research non-profit in the United States. Diabetes affects millions of Americans, with over 100,000 deaths attributed to the disease each year, disproportionately impacting communities of color. The financial burden of diabetes, including medical expenses and treatment costs, totals around $400 billion annually, indicating a significant challenge in combating …

Read more

Diabetes Drug Breakthrough: New Research Suggests GLP-1R Agonists Could Slow Parkinson’s Progression

by

Paris, France – A recent study conducted in Paris, France suggests that a drug similar to those used in “skinny jabs” could potentially slow down the progression of symptoms associated with Parkinson’s disease. Parkinson’s is a neurodegenerative condition that affects over 10 million people globally, resulting in the gradual loss of nerve cells in the brain and leading to movement difficulties, balance issues, and memory problems. While current treatments aim to manage symptoms, there is …

Read more

Diabetes Drug Breakthrough: Lixisenatide Slows Parkinson’s Progression, Researchers Reveal

by

London, England – A recent study suggests that a diabetes drug called lixisenatide may be able to slow down the progression of Parkinson’s disease symptoms. Parkinson’s is a neurodegenerative disorder affecting more than 10 million people worldwide, leading to movement, balance, and memory issues over time. While treatments can help manage symptoms, there is currently no cure available. In the realm of medical research, glucagon-like peptide 1 receptor agonists, specifically a diabetes medication known as …

Read more

Artificial Pancreas Revolution: NHS Offers Breakthrough Diabetes Technology to Thousands – Click Here to Learn More!

by

London, England – Tens of thousands of people with type 1 diabetes in England are set to benefit from a groundbreaking technology known as an artificial pancreas. This innovative system utilizes a glucose sensor under the skin to automatically calculate and deliver insulin via a pump, offering a new way to manage this chronic condition. The National Health Service (NHS) will soon begin reaching out to adults and children who could benefit from this cutting-edge …

Read more

**Gestational Diabetes Alert: Metformin Effects Revealed in Offspring Brain Development Study**

by

Gestational diabetes cases have been on the rise during pregnancy, leading to the increased prescription of metformin as a treatment option. However, the effects of this oral antidiabetic medication on brain development in children are not well understood. A recent study conducted by a cross-disciplinary team from the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) shed light on the impact of metformin on pregnant animals and their offspring, revealing that while metformin benefits pregnant animals, …

Read more

**Dementia Alert: Shocking Link Found Between Diabetes, Air Pollution, and Alcohol Consumption – Learn the Risk Factors Now!**

by

London, England – A recent study has identified diabetes, air pollution, and alcohol consumption as major risk factors for dementia. Researchers analyzed brain scans of nearly 40,000 adults in the UK, aged 44 to 82, to investigate how these modifiable risk factors impact vulnerable brain regions associated with Alzheimer’s disease and schizophrenia. The study, published in Nature Communications, highlighted the importance of these vulnerable brain regions, which typically develop during adolescence and play a critical …

Read more